
Mirion’s second quarter was marked by a negative market reaction despite revenue surpassing Wall Street expectations and adjusted profit meeting consensus. Management attributed the quarter’s top-line growth to broad contributions across all six end markets, with the Medical segment benefiting from shipment timing related to tariffs, while the Nuclear & Safety segment faced some nonrecurring cost pressures. CEO Tom Logan highlighted the company’s continued progress in increasing adjusted free cash flow and optimizing its capital structure, noting, “We demonstrated continued progress on key financial and strategic objectives, most notably increasing adjusted free cash flow generation, stepping up our M&A game and optimizing our capital structure.”
Is now the time to buy MIR? Find out in our full research report (it’s free).
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
In the coming quarters, our analysts will monitor (1) the pace of nuclear power modernization projects and the conversion of the order pipeline into revenue, (2) the scaling and integration of Certrec’s digital regulatory platform within Mirion’s broader portfolio, and (3) ongoing margin expansion efforts through procurement and AI-driven efficiencies. Progress in executing large nuclear and medical contracts, as well as further developments in SMR adoption, will also be critical markers of success.
Mirion currently trades at $22.34, in line with $22.33 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Jul-29 | |
| Jul-29 | |
| Jul-28 | |
| Jul-15 | |
| Apr-30 | |
| Apr-29 | |
| Apr-28 | |
| Apr-16 | |
| Apr-08 | |
| Mar-05 | |
| Feb-26 | |
| Feb-24 | |
| Feb-20 | |
| Feb-17 | |
| Feb-17 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite